Karine Gingras

Title: Karine Gingras: Innovator in Nerve Cell Repair

Introduction

Karine Gingras is a notable inventor based in Montréal, Canada. She has made significant contributions to the field of nerve cell repair through her innovative research and development of pharmaceutical compounds. Her work focuses on the potential of substituted piperidine derivatives in promoting nerve regeneration.

Latest Patents

Karine Gingras holds a patent for 4-substituted piperidine derivatives. These compounds are designed to permeate or penetrate across nerve cell membranes, inhibiting the intracellular Rho kinase enzyme found in nerve cells. This inhibition may facilitate the repair of damaged nerves in both the central and peripheral nervous systems of mammals. The compounds have the potential to induce the regeneration or growth of neurites in mammalian nerve cells, thereby aiding in the recovery of damaged or diseased nerve tissue. Additionally, these compounds can serve as antagonists of the Rho kinase enzyme in treating various disease states.

Career Highlights

Karine is currently associated with Bioaxone Therapeutique Inc., where she continues her research and development efforts. Her work has garnered attention for its potential applications in the medical field, particularly in the treatment of nerve damage and related conditions.

Collaborations

Karine collaborates with esteemed colleagues, including Lisa McKerracher and Eryk Thouin, who contribute to her research initiatives and help advance the understanding of nerve cell repair.

Conclusion

Karine Gingras is a pioneering inventor whose work in developing substituted piperidine compounds holds promise for advancing nerve cell repair and treatment. Her contributions to the field are significant and may lead to innovative solutions for nerve damage in mammals.